Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Colan Totte Co's EBIT per Share for the
three
months ended in Mar. 2026 was 円55.15.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円217.18.
During the past 12 months, the average EBIT per Share Growth Rate of Colan Totte Co was 16.20% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 23.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 26.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Colan Totte Co's EBIT per Share or its related term are showing as below:
TSE:7792'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 20.9 Med: 24.7 Max: 28.9
Current: 23.9
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Colan Totte Co was 28.90% per year. The lowest was 20.90% per year. And the median was 24.70% per year.
TSE:7792's 3-Year EBIT Growth Rate is ranked better than 70.12% of 686
companies
in the Medical Devices & Instruments industry
Industry Median: 9.25
vs TSE:7792: 23.90
Colan Totte Co's EBIT for the
three
months ended in Mar. 2026 was 円503 Mil.
Colan Totte Co (TSE:7792) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Colan Totte Co EBIT per Share Related Terms
Colan Totte Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Colan Totte Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円217.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Colan Totte Co (TSE:7792) has a EBIT per Share of 円217.18 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Colan Totte Co and its competitors. According to the industry distribution chart, Colan Totte Co ranks #205 out of 686 companies in the Medical Devices & Instruments industry, placing it in the top 29.9%.
Is Colan Totte Co's EBIT per Share too high?
Colan Totte Co's current EBIT per Share is 円217.18. Based on the distribution chart, Colan Totte Co ranks #205 out of 686 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Colan Totte Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Colan Totte Co ranks #205 out of 686 companies for EBIT per Share. This puts Colan Totte Co in the upper half of its industry. The industry median EBIT per Share is 9.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.25, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Colan Totte Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Colan Totte Co's current EBIT per Share is 円217.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,541.46, compared to a current price of 円1,438.00 — trading 6.7% below its estimated fair value. The current EBIT per Share is 円217.18. Colan Totte Co's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current EBIT per Share is 円217.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Colan Totte Co (TSE:7792) Overvalued in 2026?
Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued.
The current stock price of 円1,438.00 is trading 6.7% below its estimated GF Value™ of 円1,541.46.
GuruFocus considers Colan Totte Co to be Fairly Valued.
Key valuation signals for TSE:7792:
EBIT per Share: 円217.18
GF Value™: 円1,541.46 vs. price of 円1,438.00 (6.7% below fair value)
No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
90GF Score
Get the complete analysis for TSE:7792
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7792 has been successfully added to your 
